Pay in 4 interest-free payments of $6.28 Learn more
Ships within 48 hours · Estimated delivery Nov 10 - Nov 15
The Future of GLP-1 and IBS Research The medical community is only just beginning to uncover the full potential of GLP-1 receptor agonists beyond diabetes and weight loss
Differentiating Tirzepatide-Induced Aches from Other Causes What clues point to the medication rather than something else
DOI: 10.1016/j.neuint.2014.01.001.Role 23
242 Additionally, UNA modification at the siRNA terminus improves siRNA stability and silencing efficacy while considerably reducing off-target effects, highlighting its potential in the development of new therapeutic siRNAs
US$ 26.96
,aspect=ignore)
US$ 25.99
US$ 22.16
US$ 21.26
US$ 26.41
US$ 21.72
US$ 28.13
US$ 24.63
